Table 2.
Laboratory results
| Case-1 | Case-2 | Case-3 | Case-4 | Case-5 | Case-6 | Case-7 | Summary | |
|---|---|---|---|---|---|---|---|---|
| COVID-19 | ||||||||
| RT-qPCR |
NPS-Neg NPW-Pos |
NPS-Neg NPW-Pos |
NPS-Pos | NPS-Neg | aNPS-Pos | aNPS-Pos | NPS-Neg | 71.4% cases positive in at least one specimen |
| Serology | Positive | Positive | Positive | Positive | Not done | Positive | Positive | 6/6, 100% positive |
| Hematology | ||||||||
| WBC (109/L) | 27.3 | 19.4 | 16 | 9.7 | 16.9 | 6.9 | 24.1 |
71.4% above range (Ref: 4–14) |
| Neutrophil (109/L) | 24.4 | 16.5 | 5.3 | 9.5 | 13.9 | 4.6 | 16.1 |
71.4% above range (Ref: 0.8–7.2) |
| Lymphocyte (109/L) | 0.9 | 0.8 | 1.2 | 0.2 | 2.1 | 0.6 | 6.5 |
71.4% below range (Ref: 1.3–8) |
| Platelets (103/mL) | 140 | 80 | 570 | 105 | 116 | 105 | 900 |
71.4% below range (Ref: 150–400) |
| Inflammatory markers | ||||||||
| CRP (mg/L) | 262.2 | 228.3 | 162 | 304.5 | 93 | 82.8 | 143 |
100% above range (Ref: 0–7.5) |
| Ferritin (ng/mL) | 324 | 581 | 377 | 334 | 326 | 341 | 621 |
100% above range (Ref: 10–56) |
| PCT (ng/mL) | 21.6 | 7.22 | 9.4 | > 50 | 2.15 | Not done | 0.59 |
6/6, 100% above range (Ref: < 0.1) |
| IL-6 (pg/mL) | 35 | 4 | Not done | Not done | 2665 | Not done | 100 |
3/4 above range (Ref: 0–16.4) |
| Coagulation | ||||||||
| PT (sec) | 16.8 | 15.1 | 18.3 | 17 | 17.5 | 15.9 | 12 |
83% above range (Ref: 11.7–15.1) |
| D-dimer (mg/L) | 7440 | 2266 | 7500 | > 7500 | 3538 | 2381 | 3060 |
100% above range (Ref: ≤500) |
| Fibrinogen (mg/dL) | 4 | 3.9 | 3.4 | 4.4 | 3.7 | 3.6 | 4.3 |
28.6% above range (Ref: 1.6–4) |
| Cardiac | ||||||||
| Troponin (ng/L) | 40 | 14 | 68 | 309 | 161 | 34 | 4 |
100% above range (Ref: 0–0.4) |
| NT-proBNP (ng/L) | 5253 | 7006 | 2314 | 2874 | 592 | 506 | 1444 |
100% above range (Ref: < 125) |
NPS nasopharyngeal swab; NPW nasopharyngeal wash; WBC white blood cell; CRP C-reactive protein; PCT procalcitonin; PT prothrombin time; NT-proBNP N-terminal B-type natriuretic peptide
aPrevious positive